Shuttle Pharmaceuticals Holdings, Inc. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 94/100
What the filing says
Shuttle Pharmaceuticals (NASDAQ: SHPH, ~$4.7M market cap) failed to file its Q2 2026 Form 10-Q by the required due date and received a NASDAQ noncompliance notice on August 28, 2026. The company must submit a compliance plan by October 27, 2026; if accepted, NASDAQ may grant a grace period until February 22, 2027 to regain compliance. Failure to regain compliance within that window triggers automatic delisting from NASDAQ.
Why this rating
Delisting threat is existential for a $4.7M microcap. Failure to meet SEC periodic filing deadlines signals severe operational/financial distress. Loss of NASDAQ listing would eliminate market access and institutional credibility.
Tradability signal
NO TRADE
No trade: only ~$0k traded in the last 30 min — too illiquid to enter and exit.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $3.70 ▲ 2.21% | at our read · backfill $3.62 | +10 min · backfill $3.61 ▼ 0.27% | +30 min · backfill $3.54 ▼ 2.21% |
The stock had already moved -2.16% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.